Stock Rating Downgrade
Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) fell significantly during the last several trading days. AZN’s current Value Trend Rating is F and the prior Rating was C. Details supporting this lower rating are included in our next report.
Recent Price Action
Astrazeneca PLC (NASDAQ: AZN) stock rose slightly by 0.04% on 3/7/25. The stock closed at $77.50. Moreover, trading volume in this advance was above average at 127% of normal. The stock has been weak relative to the market over the last nine months but has risen 2.4% during the last week.
Current PriceTarget Research Rating
Astrazeneca has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. Astrazeneca has a slightly negative Appreciation Score of 39 and a very low Power Rating of 11, resulting in the Lowest Value Trend Rating.
Be the first to comment